0      0

The Future of Manufacturing Quality in Pharma


‐ May 10, 2023 9:35am


Credits: None available.

St.Gallen works on the US FDA funded project “RiskSurve” which has just been extended to a second year. The project aims at developing a comprehensive site quality assessment based on machine learning models. Participants will understand how regulators approach site risk assessments and how to use data for risk and non-risk related decision-making.

Speaker(s):

Credits

Credits: None available.

You must be logged in and own this session in order to post comments.